.(JavaScript must be enabled to view this email address)

Valsartan Lawsuit

The Attorneys at Ketterer, Browne, and Anderson are actively investigating legal claims on behalf of patients who took blood pressure medication that contains valsartan and who were subsequently diagnosed with tumors or cancer in the kidneys or liver. Those patients who took valsartan and experienced adverse side effects may have legal recourse against the drug manufacturer.

If you or a loved one took blood pressure medication that contained valsartan and experienced the side effects described below, please contact us to discuss your potential legal claim and address any questions you have with our team of attorneys.


What is Valsartan?

Valsartan is the active ingredient in many prescription and/or generic drugs, including drugs taken to treat hypertension, heart failure, left ventricular heart failure, and left ventricular heart dysfunction resulting from a myocardial infarction. Valsartan is also routinely prescribed in conjunction with hydrochlorothiazide (HCTZ) to treat hypertension.


2018 Recalls in the US, UK

The European Medicines Agency announced in May 2018 that there is a potentially dangerous impurity in valsartan medication sourced from Zhejiang Huahai Pharmaceuticals, a China-based drug manufacturer.

In July 2018, the Food & Drug Administration (FDA) announced a recall for several varieties of generic valsartan, warning consumers of impurities in the manufacturing process that resulted in the inclusion of a substance known as N-nitrosodimethylamine (NDMA), which is known to increase the risk of cancer. NDMA, an organic chemical, is both toxic and carcinogenic when mixed with water. The Environmental Protection Agency (EPA) states that the maximum safe limit for human ingestion of NDMA is 96 nanograms.  In its investigation, the FDA noted that the contaminated valsartan lots contained unsafe levels of NDMA.

Specific iterations of valsartan and valsartan HCTZ may be contaminated with NDMA, thereby exposing users to an increased risk of cancer and other serious side effects impacting the liver and kidneys.

Many valsartan recalls been announced by the FDA to date, including products sold by many pharmaceutical companies or re-packagers. The list includes:

  • Major Pharmaceuticals
  • Actavis
  • Teva Pharmaceuticals
  • Solco Healthcare
  • A-S Medication Solutions LLC
  • AvKARE
  • RemedyRepack
  • Bryant Ranch Prepack Inc.
  • H.J. Harkins Company, Inc.
  • Lake Erie Medical, doing business as Quality Care Products LLC
  • NuCare Pharmaceuticals
  • Proficient Rx

According to the FDA, an estimated 3 million to 3.7 million patients have been prescribed medications that contain valsartan each year for a three-year period ending in 2018. According to Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, the FDA has “carefully assessed the valsartan-containing medications sold in the United States, and we’ve found that the valsartan sold by these specific companies does not meet our safety standards. This is why we’ve asked these companies to take immediate action to protect patients”. The FDA is among 22 other governmental agencies worldwide that have taken action regarding valsartan.

The FDA’s statements and studies have suggested a strong link between the presence of NDMA in valsartan and an error in the drug’s manufacturing process, stating that “the presence of NDMA [in valsartan] was unexpected and is thought to be related to changes in the way the active substance was manufactured.” As a result of this concerning issue with the manufacturing of valsartan, the FDA is conducting an in-depth investigation into the safety of the recalled lots.

The FDA’s online adverse events reporting system reveals that there have been more than 19,000 severe reports, including over 2,800 deaths, connected to valsartan-induced injury dating back to 2009.

If you have taken valsartan-based drugs that are included in the FDA recall, contact your doctor or healthcare provider immediately to discuss the appropriate next steps. According to the FDA, patients should not cease use of valsartan drugs cold turkey without first getting the advice of their doctor, as a gradual step-down from the drug may be more beneficial to the patient. Contact your doctor to discuss what course of action is best for you.


What Are the Symptoms of NDMA Exposure?

Short-term exposure to NDMA can result in liver damage. Longer-term exposure may also reduce platelet counts in the blood, as well as an increase in the occurrence of tumors in the liver, kidneys or lungs, according to the results of animal studies cited by the EPA.

Signs and symptoms of NDMA over-exposure include:

  • Headache
  • Fever
  • Nausea
  • Jaundice
  • Vomiting
  • Abdominal Cramps
  • Enlarged Liver
  • Dizziness
  • Reduced function of liver, kidneys, and lungs

Valsartan containing NDMA can also cause or exacerbate symptoms of kidney disease, which include weight gain and swelling in hands, feet or ankles. The NDMA toxins can also increase potassium levels in the blood, which is often problematic for patients with heart or kidney conditions.


What should I do if I have taken valsartan?

If you or a loved one took recalled valsartan and subsequently developed complications such as liver cancer, kidney cancer, or tumors, please call our attorneys to discuss your next steps and possible legal recourse against valsartan manufacturers.